---
module: 023-01
language: en
chapter: 23
title: "Hypothalamic-Pituitary Control and Endocrine Feedback"
module_title: "Foundations"
source_sha256: 515b35431b6db8672ab382f7eedf09986c7fdb497d1b1749bc9d38b85db02130
---
# Hypothalamic-pituitary control and endocrine feedback

## Hormones, classes, and binding
### Level reflects secretion, binding, metabolism, clearance
#### Not gland activity alone
### Peptides: precursors, vesicles, exocytosis
#### Membrane receptors and second messengers
### Steroids: from cholesterol, made on demand
#### Protein-bound, intracellular receptors, transcription
### Thyroid hormones act through nuclear receptors
### Catecholamines act through surface receptors
### Only unbound hormone reaches tissues
#### Binding changes alter total, not free activity
#### Pregnancy, oestrogen, liver disease, protein loss

## Feedback, rhythms, and dynamic testing
### Releasing hormone, trophic hormone, peripheral gland
### Primary failure: low target, high trophic
### Central failure: low target, low or normal trophic
### Autonomous secretion suppresses upstream signals
### Pulsatile and circadian secretion
#### Gonadotropin-releasing hormone must be intermittent
#### Continuous exposure suppresses the axis
#### Cortisol peaks near waking, falls at midnight
### A single value can mislead
### Suppression tests: can autonomy be restrained
### Stimulation tests: can reserve respond

## Hypothalamus and anterior pituitary
### Regulatory peptides enter portal circulation
### Releasing hormones drive trophic hormones
### Somatostatin inhibits growth and thyroid-stimulating hormones
### Dopamine tonically inhibits prolactin
### Masses secrete, compress, or both
#### Upward: optic chiasm, temporal fields
#### Lateral: ocular motor nerves, sympathetic fibres
### Tumour haemorrhage or infarction
#### Headache, visual loss, ophthalmoplegia
#### Acute adrenal insufficiency

## Posterior pituitary and water balance
### Vasopressin made in hypothalamic nuclei
### Stimuli: rising osmolality, volume depletion
### V2 receptors insert aquaporins
### Diabetes insipidus: large dilute urine volumes
#### Hypernatraemic dehydration without water access
#### Central responds to desmopressin
#### Nephrogenic: correct cause, reduce solute load
#### Primary polydipsia can mimic
### Inappropriate antidiuresis
#### Low sodium, concentrated urine
#### Rapid correction risks osmotic demyelination

## Growth hormone
### Linear growth via insulin-like growth factor one
### Direct lipolysis and insulin resistance
### Insulin-like growth factor one integrates secretion
### Excess: gigantism before closure, acromegaly after
#### Glucose fails to suppress growth hormone
### Deficiency: poor growth, reduced lean mass
#### Random value unhelpful, stimulation testing

## Prolactin
### Suckling reduces dopamine, raises prolactin
### Falling sex steroids permit lactation
### High prolactin suppresses gonadotropin-releasing hormone
#### Infertility, sexual dysfunction, bone loss
#### Galactorrhoea neither required nor specific
### Causes: tumour, stalk, drugs, hypothyroidism
### Repeat mild rise, check macroprolactin
### Dopamine agonists shrink prolactinomas
### Distinguish tumour from drug or stalk effect

## Hypopituitarism
### Tumours, surgery, radiation, postpartum haemorrhage
### Deficits emerge gradually, variable order
### Adrenocorticotropic deficiency immediately dangerous
#### Aldosterone kept by renin-angiotensin system
### Replace cortisol before thyroid hormone
#### Thyroid first can precipitate crisis

## Functional pituitary tumours
### Adrenocorticotropic tumours: pituitary cortisol excess
### Thyroid-stimulating tumours: central hyperthyroidism
### Gonadotroph tumours often non-functioning
### Surgery, drugs, radiotherapy, replacement
### Long-term surveillance for late change

## Investigation in practice
### Start from phenotype and medicines
### Measure target with controlling hormone
### Repeat surprising results
### Imaging follows biochemistry
#### Incidental lesions do not prove secretion
### Urgent: vision, apoplexy, sodium, adrenal crisis
